CVS Health CVS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 179.4%+4.3pp | 179.4%+8.4pp | 179.1%+13.4pp | 177.8%+16.3pp | 175.1%+16.8pp | |
| Operating margin | 6.2%-4.6pp | 7.3%-4.5pp | 8.4%-4.9pp | 9.7%-5.0pp | 10.8%-2.4pp | |
| Net margin | 2.4%-3.5pp | 3.1%-3.5pp | 3.9%-3.8pp | 5.2%-3.7pp | 6%-1.7pp | |
| Returns | ||||||
| Return on equity | 12.7%-16.8pp | 15.9%-16.7pp | 19.7%-18.2pp | 25.7%-17.3pp | 29.5%-7.7pp | |
| Return on invested capital | 18.1%-5.7pp | 19.2%-4.7pp | 19.5%-7.6pp | 22.7%-7.4pp | 23.7%-3.3pp | |
| Efficiency | ||||||
| Asset turnover | 6.3×+0.4× | 6.2×+0.3× | 6×+0.2× | 6×+0.1× | 5.9×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3.3×+0.1× | 3.3×0.0× | 3.3×-0.1× | 3.2×-0.2× | 3.3×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1.8×-1.8× | 1.9×-1.8× | 2.8×-0.8× | 2.8×-0.8× | 3.6×0.0× | |
| Net debt / EBITDA | 9.8×-6.4× | 9.8×-6.5× | 14.8×+0.5× | 12.5×-0.1× | 16.2×+1.3× | |
| Per Share | ||||||
| Book value per share | $238.13-0.7% | $238.44+0.5% | $239.13+1.0% | $241.19+2.7% | $239.78+3.4% | |
| Valuation | ||||||
| Market capitalization | $373.22B+26.5% | $367.27B+18.4% | $323.02B-9.1% | $306.5B-16.2% | $295.15B-22.4% | |
| Price / earnings | 310.9×+256× | 295.9×+244× | 251.2×+199× | 63.1×+16.5× | 54.5×-11.7× | |
| Price / sales | 0.9×+0.1× | 0.9×+0.1× | 0.8×-0.1× | 0.8×-0.2× | 0.8×-0.3× | |
| Price / book | 4.9×+1.0× | 4.9×+0.7× | 4.3×-0.5× | 4×-0.9× | 3.9×-1.2× | |
| EV / EBITDA | 45.7×+9.2× | 43×+6.5× | 41.5×+5.6× | 34.7×+1.3× | 36.5×-3.2× | |
| Dividend yield | 14.6%-3.9pp | 14.8%-2.9pp | 17.4%+2.6pp | 18.1%+4.0pp | 18.5%+5.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CVS Health's profit margins?
- CVS Health (CVS) runs a 44.7% gross margin and a 1.5% operating margin, with a 0.7% net margin.
- Where do CVS Health's ratios come from?
- Every ratio is computed from CVS Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
